This inventor holds 1 USPTO granted patent. Top assignee: Japanese Foundation for Cancer Research. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Takeru Wakatsuki: Innovator in Cancer Research
Introduction
Takeru Wakatsuki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer research, particularly in the development of biomarkers for predicting therapeutic effects of antibody drugs.
Latest Patents
Wakatsuki holds a patent titled "Biomarkers, test method, and test kit for predicting therapeutic effect of anti-VEGFR-2 antibody drug." This patent focuses on predicting the therapeutic effect and prognosis after administering an anti-VEGFR-2 antibody drug, specifically ramucirumab. The prediction is achieved by measuring various biomarkers, including VEGF-A, VEGF-D, sVEGFR-2, SDF-1α, and cNRP1. This innovation provides a valuable tool for assessing the effectiveness of cancer treatments.
Career Highlights
Wakatsuki is affiliated with the Japanese Foundation for Cancer Research, where he continues to advance his work in the field. His research has the potential to improve patient outcomes by enabling more personalized treatment strategies.
Collaborations
Wakatsuki collaborates with notable colleagues, including Tetsuo Mashima and Hiroyuki Seimiya, who contribute to his research efforts and enhance the impact of his work.
Conclusion
Takeru Wakatsuki is a key figure in cancer research, with a focus on innovative solutions for predicting treatment efficacy. His contributions are paving the way for advancements in personalized medicine and improving therapeutic outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile